Evidence map›Paper›PMID 27373545›Full record

ReviewReviews in medical virology2016

The role of microRNAs in respiratory viral infection: friend or foe?

Alireza Tahamtan, Christopher S Inchley, Mona Marzban, Masoumeh Tavakoli-Yaraki, Majid Teymoori-Rad, Britt Nakstad, Vahid Salimi

Open access · bronzeAbstract readReview
In one paragraph

Review in Reviews in medical virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Alterations in CX3CL1 Levels and Its Role in Viral Pathogenesis.International journal of molecular sciences · 2024
    Review
  10. Review
  11. Viral MicroRNAs in Herpes Simplex Virus 1 Pathobiology.Current pharmaceutical design · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Alireza TahamtanDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Christopher S InchleyDepartment of Pediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway.
Mona MarzbanDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Masoumeh Tavakoli-YarakiDepartment of Biochemistry, school of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Majid Teymoori-RadDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Britt NakstadDepartment of Pediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway.
Vahid SalimiDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRAkershus University Hospital · NOIran University of Medical Sciences · IRUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) have emerged as a class of regulatory RNAs in host-pathogen interactions. Aberrant miRNA expression seems to play a central role in the pathology of several respiratory viruses, promoting development and progression of infection. miRNAs may thus serve as therapeutic and prognostic factors for respiratory viral infectious disease caused by a variety of agents. We present a comprehensive review of recent findings related to the role of miRNAs in different respiratory viral infections and discuss possible therapeutic opportunities aiming to attenuate the burden of viral infections. Our review supports the emerging concept that cellular and viral-encoded miRNAs might be broadly implicated in human respiratory viral infections, with either positive or negative effects on virus life cycle. Copyright © 2016 John Wiley & Sons, Ltd.

Indexed as

Gene Expression RegulationHost-Pathogen InteractionsHumansMicroRNAsRespiratory Tract InfectionsVirus DiseasesMicroRNAs

Identifiers

PMID27373545
PMCPMC7169129
OpenAlexW2466393177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.